Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Lightbridge
LTBR
$259M
| $90K | ﹤0.01% |
19,038
-19,279
| -50% | -$115K |
|
3252
Phunware
PHUN
$43.8M
| $88.5K | ﹤0.01% |
+17,027
| New | +$94K |
|
3253
Ovid Therapeutics
OVID
$440M
| $86.9K | ﹤0.01% |
92,971
-11,040
| -11% | -$12.4K |
|
|
SGMO
3254
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $86K | ﹤0.01% |
84,270
-409,416
| -83% | -$748K |
|
3255
Barnwell Industries
BRN
$13.7M
| $84.1K | ﹤0.01% |
55,713
-7,529
| -12% | -$13.7K |
|
|
BRFS
3256
DELISTED
BRF SA
BRFS
| $81.8K | ﹤0.01% |
20,096
-8,129
| -29% | -$35.3K |
|
3257
Astrotech Corp
ASTC
$12.9M
| $80.2K | ﹤0.01% |
11,930
+1,579
| +15% | +$11.7K |
|
3258
Journey Medical
DERM
$174M
| $80K | ﹤0.01% |
+20,455
| New | +$112K |
|
3259
Blink Charging
BLNK
$74.1M
| $79K | ﹤0.01% |
+56,851
| New | +$100K |
|
|
ICAD
3260
DELISTED
iCAD Inc
ICAD
| $78.2K | ﹤0.01% |
42,631
-6,468
| -13% | -$11.5K |
|
3261
RAVE Restaurant Group
RAVE
$43.9M
| $77.9K | ﹤0.01% |
30,449
+6,682
| +28% | +$18.7K |
|
|
AZUL
3262
DELISTED
Azul
AZUL
| $76.7K | ﹤0.01% |
45,602
+433
| +1% | +$1.13K |
|
3263
Energy Vault
NRGV
$498M
| $76.7K | ﹤0.01% |
33,637
+22,528
| +203% | +$37.3K |
|
3264
Stabilis Solutions
SLNG
$89.1M
| $76.6K | ﹤0.01% |
14,310
+1,531
| +12% | +$7.57K |
|
3265
Shattuck Labs
STTK
$651M
| $76.1K | ﹤0.01% |
62,956
-109,300
| -63% | -$135K |
|
3266
Lisata Therapeutics
LSTA
$10.6M
| $75.2K | ﹤0.01% |
25,226
+7,886
| +45% | +$22.6K |
|
3267
ImmunityBio
IBRX
$7.3B
| $71.6K | ﹤0.01% |
27,966
+16,954
| +154% | +$70.6K |
|
3268
Zevia
ZVIA
$116M
| $68K | ﹤0.01% |
16,239
| – | – |
|
3269
Usio Inc
USIO
$53.8M
| $67.8K | ﹤0.01% |
46,421
| – | – |
|
3270
SOPHiA GENETICS
SOPH
$467M
| $67.6K | ﹤0.01% |
21,619
+4,115
| +24% | +$14K |
|
3271
NextCure
NXTC
$22.1M
| $66.2K | ﹤0.01% |
7,154
| – | – |
|
3272
Cineverse
CNVS
$56.4M
| $65.5K | ﹤0.01% |
+17,952
| New | +$51.1K |
|
|
NKLA
3273
DELISTED
Nikola Corporation Common Stock
NKLA
| $65.1K | ﹤0.01% |
54,724
-12,522
| -19% | -$35.8K |
|
3274
Copel
ELPC
$8.63B
| $64.1K | ﹤0.01% |
12,181
-98
| -0.8% | -$574 |
|
3275
Precigen
PGEN
$1.97B
| $63.4K | ﹤0.01% |
57,082
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.